News
ALPMF
13.45
NaN%
--
J.P. Morgan Sticks to Their Hold Rating for Astellas Pharma (ALPMF)
TipRanks · 1d ago
Weekly Report: what happened at ALPMF last week (0622-0626)?
Weekly Report · 1d ago
Merck gains EU approval of Keyruda, Padcev combo for bladder cancer
Seeking Alpha · 6d ago
Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circle
Benzinga · 06/23 17:46
Sangamo files for restructuring, plans asset sales to Lilly, Astellas
TipRanks · 06/23 16:21
Weekly Report: what happened at ALPMF last week (0615-0619)?
Weekly Report · 06/22 09:57
Weekly Report: what happened at ALPMF last week (0608-0612)?
Weekly Report · 06/15 09:58
Astellas Wraps Up Real-World Safety Study on Smyraf, Clarifying RA Market Outlook
TipRanks · 06/10 16:31
AbCellera: Q3 Hot Flashes Data Drop Aside, This Stock Is A Difficult Sell
Seeking Alpha · 06/09 13:18
Weekly Report: what happened at ALPMF last week (0601-0605)?
Weekly Report · 06/08 09:55
Astellas Pharma (ALPMF) Receives a Buy from Bank of America Securities
TipRanks · 06/05 13:22
Pfizer and Astellas Advance New Bladder Cancer Combo in Early Clinical Trial
TipRanks · 06/04 16:34
Analysts Offer Insights on Healthcare Companies: Astellas Pharma (OtherALPMF), AbbVie (ABBV) and Replimune Group (REPL)
TipRanks · 06/02 12:50
Weekly Report: what happened at ALPMF last week (0525-0529)?
Weekly Report · 06/01 09:58
Astellas Pharma Cuts Director Slate After Outside Director Resigns
TipRanks · 05/29 07:23
Astellas Pharma (ALPMF) Gets a Buy from Macquarie
TipRanks · 05/28 10:10
Ironwood, AbbVie win U.S. label expansion for Linzess in pediatric constipation
Seeking Alpha · 05/27 15:00
Astellas Launches Five-Year CSP2026 Plan Targeting Pipeline-Led Record Revenues
TipRanks · 05/26 07:05
UBS Reaffirms Their Hold Rating on Astellas Pharma (ALPMF)
TipRanks · 05/25 10:26
Weekly Report: what happened at ALPMF last week (0518-0522)?
Weekly Report · 05/25 10:00
More
Webull provides a variety of real-time ALPMF stock news. You can receive the latest news about Astellas Pharma through multiple platforms. This information may help you make smarter investment decisions.
About ALPMF
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.